NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
Alliance Foundation Trials, LLC.
Eli Lilly and Company
Radiation Therapy Oncology Group
Eli Lilly and Company
PrECOG, LLC.